Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Clinical trial NCT01560793 · COMPLETED
Trial details
- NCT number
- NCT01560793
- Sponsor
- VaxInnate Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.